CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury.
Lodka D, Zschummel M, Bunse M, Rousselle A, Sonnemann J, Kettritz R, Höpken UE, Schreiber A.
Ann Rheum Dis. 2024 Mar 12;83(4):499-507. doi: 10.1136/ard-2023-224875.
Crescentic glomerulonephritis in children.
Mayer U, Schmitz J, Bräsen JH, Pape L.
Pediatr Nephrol. 2020 May;35(5):829-842. doi: 10.1007/s00467-019-04436-y. Epub 2020 Feb 12.
Drug-induced glomerulopathies.
Izzedine H, Launay-Vacher V, Bourry E, Brocheriou I, Karie S, Deray G.
Expert Opin Drug Saf. 2006 Jan;5(1):95-106. doi: 10.1517/14740338.5.1.95.
Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuli.
Hu P, Xiao H, Alba MA, Atkins HM, Gou S, Hu Y, Gomez JC, Jania CM, Martin JR, Morrison TE, Tilley SL, Heise MT, Doerschuk CM, Falk RJ, Jennette JC.
Kidney Int. 2024 Nov;106(5):870-886. doi: 10.1016/j.kint.2024.08.022. Epub 2024 Aug 30.
Crescentic lupus glomerulonephritis.
Yeung CK, Wong KL, Wong WS, Ng MT, Chan KW, Ng WL.
Clin Nephrol. 1984 May;21(5):251-8.
[Crescentic glomerulonephritis].
Ueno M, Arakawa M.
Nihon Rinsho. 1994 Aug;52(8):2082-8.
Massive hematuria with rashes: Type II crescentic glomerulonephritis.
Lin Z, Chen C, Xu Y.
Am J Med Sci. 2024 Aug;368(2):e11-e12. doi: 10.1016/j.amjms.2023.11.015. Epub 2023 Nov 22.
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
Moroni G, Ponticelli C.
Autoimmun Rev. 2014 Jul;13(7):723-9. doi: 10.1016/j.autrev.2014.02.007. Epub 2014 Mar 19.
Mesangiocapillary glomerulonephritis.
D'Amico G, Ferrario F.
J Am Soc Nephrol. 1992 Apr;2(10 Suppl):S159-66. doi: 10.1681/ASN.V210s159.
Crescentic glomerulonephritis: data from the Spanish Glomerulonephritis Registry.
Quiroga B, Vega A, Rivera F, López-Gómez JM; Spanish Registry of Glomerulonephritis.
Intern Med J. 2015 May;45(5):557-62. doi: 10.1111/imj.12725.
